Exploring indigenous perspectives on tobacco tax: how some Māori families are responding in Aotearoa New Zealand.


Journal

Tobacco control
ISSN: 1468-3318
Titre abrégé: Tob Control
Pays: England
ID NLM: 9209612

Informations de publication

Date de publication:
12 2021
Historique:
received: 16 07 2020
revised: 09 12 2020
accepted: 11 12 2020
pubmed: 14 1 2021
medline: 15 12 2021
entrez: 13 1 2021
Statut: ppublish

Résumé

High smoking prevalence rates, combined with a steep tax on tobacco and lower household income, mean that 5% of Māori (indigenous) whānau (family unit) expenditure in New Zealand is on tobacco. This paper outlines whānau perceptions of, and behavioural responses to, increasing tobacco tax. This qualitative study was informed by the Kaupapa Māori theory and used a simplified interpretive phenomenological analysis thematic hybrid methodology. A semistructured, open-ended interview guide was designed and used in one-off focus group interviews. Interviews were separately conducted with each of 15 whānau units. A total of 72 participants, most of whom were smokers, took part in the interviews carried out in two geographical regions: one rural/provincial and one urban. Whānau were concerned about the rising cost of tobacco. However, this concern had not generally translated into quit attempts. Whānau had instead developed innovative tobacco-related practices. Working collectively within their whānau, they were able to continue to smoke, although in a modified fashion, despite the rising costs of tobacco. Whānau thereby resisted the intended outcome of the government's tobacco tax which is to reduce rates of smoking prevalence. In the face of significant government disinvestment in New Zealand tobacco control over the last 10 years, hypothecated taxes should be used to scale up Māori-specific cessation and uptake prevention programmes, supporting authentic Māori partnerships for endgame solutions including restricting the availability and appeal of tobacco.

Identifiants

pubmed: 33436460
pii: tobaccocontrol-2020-056097
doi: 10.1136/tobaccocontrol-2020-056097
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e144-e149

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Heather Gifford (H)

Whakauae Research for Maori Health and Development, Whanganui, New Zealand heather@whakauae.co.nz.

Andrew Waa (A)

Department of Public Health, Wellington School of Medicine, University of Otago, Wellington, New Zealand.

Lynley Cvitanovic (L)

Whakauae Research for Maori Health and Development, Whanganui, New Zealand.

Gill Potaka-Osborne (G)

Whakauae Research for Maori Health and Development, Whanganui, New Zealand.

Anania Kerehoma-Cook (A)

Kokiri Marae Keriana Olsen Trust, Wellington, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH